Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01071902 · ClinicalTrials.gov registry record · Phase 3
Safety and Efficacy of Moxidex Otic
A Phase 3 study, sponsored by Alcon Research.
- Terminated
- Registry status
- Phase 3
- Development phase
- 400
- Enrollment target
NCT01071902 is a Phase 3 study that was terminated before completion, run by Alcon Research. The registered enrollment target is 400 participants.
The verdict
NCT01071902, a Phase 3 study, was terminated before completion, sponsored by Alcon Research.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 400 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if Moxidex otic solution is safe and effective in treating middle ear infections in patients with ear tubes.
Interventions
- OTHER Vehicle
- DRUG Moxidex otic solution
- DRUG Moxifloxacin otic solution
- DEVICE Tympanostomy tubes
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2010-02 |
| Est. Completion | 2011-10 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01071902
The ClinicalTrials.gov registry entry for NCT01071902 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alcon Research, which has 275 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Vehicle is the first listed.
NCT01071902 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01071902 about?
NCT01071902 is a clinical study titled "Safety and Efficacy of Moxidex Otic". The purpose of this study is to determine if Moxidex otic solution is safe and effective in treating middle ear infections in patients with ear tubes.
What is the current status of trial NCT01071902?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 400 participants. The study started on 2010-02. Estimated completion is 2011-10.
What interventions are being tested in trial NCT01071902?
The interventions under investigation include: Vehicle (OTHER), Moxidex otic solution (DRUG), Moxifloxacin otic solution (DRUG), Tympanostomy tubes (DEVICE).
Who is sponsoring clinical trial NCT01071902?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.